Scarica l'app Stockscreener
35.48
0.06%
-0.02
Dopo l'orario di chiusura:
35.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CSTL Giù?
Forum
Previsione
Castle Biosciences Inc Borsa (CSTL) Ultime notizie
Preset sale plan at Castle Biosciences (CSTL) covers 29K shares - Stock Titan
Castle Biosciences, Inc.JAAD Publication Shows Improved Performance of DecisionDx-SCC - marketscreener.com
Responsive Playbooks and the CSTL Inflection - Stock Traders Daily
Castle Biosciences, Inc. (CSTL) Stock Price Quote Today & Current Price Chart - Capital.com
JAAD Publication Shows Improved Performance of DecisionDx®-SCC - AdVantageNews.com
CSTL Looks 8.4% Overvalued on GF Value™ - GuruFocus
SciBase receives additional order from Castle Biosciences, advancing the collaboration - Yahoo Finance
Bank of New York Mellon Corp Invests $2.34 Million in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Stock Price Forecast. Should You Buy CSTL? - StockInvest.us
Castle Biosciences, Inc. $CSTL Shares Sold by Bank of America Corp DE - MarketBeat
Castle Biosciences COO Oelschlager sells $138,642 in shares By Investing.com - Investing.com Nigeria
Castle Biosciences COO Oelschlager sells $138,642 in shares - investing.com
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares By Investing.com - Investing.com South Africa
Castle Biosciences (NASDAQ:CSTL) Beats Estimates As Momentum Builds - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 1,730 Shares - GuruFocus
Castle Biosciences (CSTL) Slips 2.4% to $32.62: Key Support in FocusNews Sentiment - vinanet.vn
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares - Investing.com
Empowered Funds LLC Acquires New Shares in Castle Biosciences, Inc. $CSTL - marketbeat.com
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells $412,609.60 in Stock - marketbeat.com
CSTL stock gains as institutional investor builds position and recent results support growth story - ad-hoc-news.de
CSTL Q2 2026 Earnings: Loss Narrows to -$0.07 per Share, Delivering an 83% BeatFull Year Guidance - vinanet.vn
Man Group plc Takes $2.59 Million Position in Castle Biosciences, Inc. $CSTL - MarketBeat
3,291,963 Shares in Castle Biosciences, Inc. $CSTL Purchased by BlackRock Inc. - MarketBeat
(CSTL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Castle Biosciences, Inc. $CSTL Shares Acquired by Algert Global LLC - MarketBeat
Castle Biosciences, Inc. (CSTL) Is Up 15.46% in One Week: What You Should Know - Yahoo Finance
Castle Biosciences Inc. (CSTL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Jefferies Financial Group Inc. Acquires New Shares in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences CCO Tobin Juvenal Sells 9,050 Shares via Rule 10b5-1 Plan - Kalkine Media
Castle Biosciences CCO Tobin W sells $317k in shares By Investing.com - Investing.com India
Castle Biosciences CCO Tobin W sells $317k in shares - Investing.com
Tobin Juvenal Sells 9,050 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Makes New $7.91 Million Investment in Castle Biosciences, Inc. $CSTL - marketbeat.com
Insider Selling: Castle Biosciences (NASDAQ:CSTL) COO Sells $426,257.28 in Stock - marketbeat.com
Castle Biosciences (CSTL) Slides 2.77% as Shares Approach Key Support at $32.33Ichimoku Kumo Twist - vinanet.vn
Castle Biosciences CCO Tobin W sells $51,190 in stock By Investing.com - Investing.com Canada
Parkman Healthcare Partners LLC Invests $3.45 Million in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences (NASDAQ: CSTL) CCO lines up sale of 22,500 shares - Stock Titan
Castle Biosciences officer plans $841K share sale | CSTL SEC FilingForm 144 - Stock Titan
Castle Biosciences surges 67% after InvestingPro Fair Value call By Investing.com - Investing.com Nigeria
Castle Biosciences (NASDAQ:CSTL): Why Does Its Latest Move Matter Now? - kalkinemedia.com
Is Castle Biosciences Inc (CSTL) Overvalued After 3.9% Rally? GF - GuruFocus
CFO & Treasurer Of Castle Biosciences Sold 41% Of Their Shares - Sahm
Castle Biosciences to Participate in Upcoming Investor Conferences - Sahm
238,204 Shares in Castle Biosciences, Inc. $CSTL Acquired by Advisors Capital Management LLC - MarketBeat
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Castle Biosciences CCO Tobin W Juvenal Sells 1,730 Shares via 10b5-1 Trading Plan - Kalkine Media
Castle (CSTL) Results Versus Estimates: EPS Beats Its Estimate in the Current Update; After Earnings: The Stock Ends Up 5.75% for the Current SessionEarnings Season Outlook - vinanet.vn
Castle Biosciences CFO Frank Stokes Sells 24,908 Shares in Open Market Transaction - Kalkine Media
Castle Biosciences (CSTL) CFO sells 24,908 company shares - Stock Titan
Castle Biosciences (CSTL) Edges Lower to $29.66: Diagnostic Stock Holds Key Support ZoneProfitability Factor - vinanet.vn
Castle Biosciences Gets Approval for Dual Listing on Nasdaq Texas - marketscreener.com
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):